Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

1206 results about "Ophiocordyceps sinensis" patented technology

Ophiocordyceps sinensis (formerly known as Cordyceps sinensis), is known in English colloquially as caterpillar fungus, or by its more prominent names yartsa gunbu (Tibetan: དབྱར་རྩྭ་དགུན་འབུ་, Wylie: dbyar rtswa dgun 'bu, literally "summer grass, winter worm"), or dōng chóng xià cǎo (Chinese: 冬蟲夏草) or Yarsha-gumba or Yarcha-gumba, यार्सागुम्बा (in Nepali language). It is an entomopathogenic fungus (a fungus that grows on insects) in the family Ophiocordycipitaceae. It is mainly found in the meadows above 3,500 meters (11,483 feet) in the Himalayan regions of Nepal, Bhutan, India and Tibet. It parasitizes larvae of ghost moths and produces a fruiting body which used to be valued as a herbal remedy. However, the fruiting bodies harvested in nature usually contain high amounts of arsenic and other heavy metals so they are potentially toxic and sales have been strictly regulated by the CFDA (China Food and Drug Administration) since 2016.

Qualitative and quantitative analysis method for polyoses

The invention relates to a qualitative and quantitative analysis method for polyoses, which comprises the following steps: (1) the zymohydrolysis and the verification of the polyoses: measuring the content of a polyoses water solution by a colorimetric method; (2) comparing the change of a polyoses mapping before and after zymohydrolysis by HPSEC-ELSD analysis; (3) saccharide ingredient direct HPLC analysis of a polyoses zymohydrolysis solution or HPLC analysis after pre-column derivatization: identifying polyoses mapping and chromatogram peaks by taking a standard monosaccharose, a uronic acid, a disaccharide, and the like as contrasts and taking a chromatogram peak mass-to-charge ratio as reference, and using stable characteristic sections as a quantitative analysis index; and (4) realizing the qualitative and quantitative analysis of the polyoses by establishing polyoses zymohydrolysis responding characteristics and polyoses zymohydrolysis mapping which are based on structural information through the independent or combining application of the steps. The qualitative and quantitative analysis method can be used for the identification and quantitative measurement of the polyoses of traditional Chinese medicine, such as panax, panax pseudoginseng, gen-seng, aweto, cordyceps, ganoderma lucidum, fomes japonica, milk veteh, angelica, and the like and provides an effective method for controlling the quality of the polyoses and the products thereof.
Owner:李绍平

Medicine composition for treating fatigue syndrome of sub-healthy people and hypodynamia and inferior immunologic function of patient with acquired immune deficiency syndrome and preparation method thereof

The invention discloses a novel traditional Chinese medicine composition for treating the fatigue syndrome of sub-healthy people and the fatigue, the hypodynamia and the inferior immunologic function of a patient with acquired immune deficiency syndrome and a preparation method thereof. The main components of the traditional Chinese medicine composition comprise the following several raw materials of medicines: crude astragalus root, yam, white peony root, radix codonopsis pilosulae, angelica, solomonseal, ginseng, tuber fleeceflower, American ginseng, antler, aweto, ophiopogon root, Chinese wolfberry and prepared rehmannia root. The medicine composition can be prepared into any common oral preparation according to a conventional traditional Chinese medicine preparation method. The invention can obviously improve sub-health, fatigue syndrome, fatigue and hypodynamia of patients with acquired immune deficiency syndrome, enhances the self immunity and has the advantages of definite curative effect, obvious effect, convenient taking, quick acting, wide suitable crowd, no toxic or side effect and the like.
Owner:TAIYI HEPU BEIJING RES INST OF TCM

Fungal pharmaceutical mycoplasm with blood sugar lowering efficacy and preparation method thereof

The invention belongs to the field of biofermentation engineering. A pharmaceutical medium and a fungal strain which have blood sugar lowering efficacy are used as bidirectional fermentation raw materials, wherein the pharmaceutical medium is mainly composed of the following raw materials: cornel, gynostemma, momordica grosvenori, winged euony twigs, balsam pear and polyrhachis vicina; the fungalstrain is composed of the following strains: inonotus obliquus, cordyceps, phellinus igniarius, polystictus versicolor, and grifola frondosa; and bi-directional multi-fungi fermentation is carried out between multiple edible and pharmaceutical fungi and Chinese herbal medicines by a bidirectional fermentation process, thus organisms in two kingdoms or three kingdoms are organically combined to obtain an entirely new blood-sugar-lowering pharmaceutical mycoplasm product. The obtained product can generate 1+1>2 physiological function efficiency for hypoimmunity, has the actions of obviously lowering blood sugar but not increasing insulin concentration, has significant positive effects on helping treating and controlling diabetic complications, and can be used as an oral medicament for preventing and treating diabetes or a health-care product for adjusting blood sugar.
Owner:DALIAN BAIXIANGJU BIOLOGICAL TECH

Process for abstracting mycelium polysaccharide by cordyceps fermentation

The invention discloses a method for extracting and purifying polysaccharide from a fermented mycelium of Cordyceps sinensis. The method comprises the following steps of: using the fermented mycelium of Cordyceps sinensis as a raw material to produce crude polysaccharide of the Cordyceps sinensis via degreasing, aqueous extraction, concentration and alcohol precipitation; then, redissolving the crude polysaccharide into distilled water, deproteinizing the crude polysaccharide by Sevag, decoloring the deproteinized crude polysaccharide by H2O2, dialyzing the decolored crude polysaccharide, and precipitating the dialyzed crude polysaccharide by alcohol to produce primarily purified polysaccharide; finally, purifying the primarily purified polysaccharide by ion-exchange chromatography, collecting different produced compositions stepwisely, dialyzing the compositions, precipitating the dialyzed compositions by alcohol, drying the precipitated compositions to produce the polysaccharide of the Cordyceps sinensis after the precipitated compositions are orderly washed by absolute ethyl alcohol, acetone, aether and so on. In the produced polysaccharide of the Cordyceps sinensis, MPS2 is identified to be homogeneous polysaccharide by ultraviolet absorption spectrum and gel chromatography, with high content of total sugar. The method has the advantages of simple and convenient extraction steps and low cost.
Owner:INST OF MICROBIOLOGY - CHINESE ACAD OF SCI

An anticancer drug composition and a traditional Chinese medicine composition

The invention discloses an anti-cancer medicinal composition, which comprises 15-70 parts by weight of plant polysaccharide and mainly comprises the following medicinal crops or mainly comprises a Chinese medicinal composition prepared by the following medicinal crops in parts by weight: 18-22 parts of astragalus, 13-17 parts of ginseng, 22-26 parts of angelica, 13-17 parts of honeysuckle and 13-17 parts of root of straight ladybell, wherein the plant polysaccharide is selected from one more of ganoderma lucidum polysaccharide, lentinan polysaccharide, cordyceps sinensis polysaccharide, coriolus versciclor polysaccharide, agaricus blazei polysaccharide, hericium erinaceus polysaccharide, maitake polysaccharide, ginkgo polysaccharide and ginseng polysaccharide. The invention also disclosesthe Chinese medicinal composition in the anti-cancer medicinal composition. The anti-cancer medicinal composition provided by the invention is used for treating advanced cancer in the case that surgery and concurrent chemoradiotherapy are unsuitable or invalid, particularly has an obvious treatment effect on the advanced gastric cancer; the total effectiveness ratio reaches about 90 percent; the total cure rate reaches about 30 percent; the three-year survival rate reaches about 40 percent; and the five-year survival rate reaches about 25 percent.
Owner:浦元清 +1

Method for culturing mycelia and sporocarps of aweto

ActiveCN101843196ASolve the problem that cannot be cultivated on a large scaleHorticultureBiotechnologyAcute toxicity testing
The invention belongs to the technical field of fungus culture, particularly to a method for culturing mycelia and sporocarps of aweto, which solves the problem that artificial aweto in the prior art can not be cultured in a large scale. The method comprises the following steps of: selecting cephalosporium acremonium and Isaria cicadae; preparing a cephalosporium acremonium liquid strain and an Isaria cicadae liquid strain; preparing a solid culture medium from corn grit, soybean flour, wheat grains, sorghum grains, silkworm chrysalis meal, whole chicken eggs, black bean coarse powder containing hulls, degreased linseed oil and a nutrient solution, wherein the nutrient solution comprises chicken blood, pine needles, carrots, black beans and cattle bone; evenly mixing, and inoculating; and culturing to obtain the sporocarps and the mycelia. The detection indicates that the sporocarps contain at least 0.02% of adenosine and at least 0.1% of cordycepin, and the mycelia contain at least 0.055% of adenosine; the finger-print test result indicates that the degree of similarity of the sporophores and the mycelia is greater than 97%; and acute toxicity experiments and long-term toxicity experiments indicate that the sporophores and the mycelia have no toxicity and can be used as substitutes of natural aweto.
Owner:杨毅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products